CHA Vaccine Research Institute (KOSDAQ:261780)

KOSDAQ:261780 Revenue

CHA Vaccine Research Institute had revenue of 370.66M KRW in the twelve months ending September 30, 2024, up 26.02% year-over-year. In the year 2023, CHA Vaccine Research Institute had annual revenue of 294.12M with 63.87% growth.

• Revenue (ttm): 370.66M
• Revenue Growth: +26.02%
• P/S Ratio: 224.83
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 83.40B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	294.12M	114.64M	63.87%
Dec 31, 2022	179.48M	-320.52M	-64.10%
Dec 31, 2021	500.00M	422.20M	542.70%
Dec 31, 2020	77.80M	-48.32M	-38.31%
Dec 31, 2019	126.11M	-47.22M	-27.24%